CBT

Cabot Corporation [CBT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CBT Stock Summary

Top 10 Correlated Stocks

CBT


In the News

08:17 07 Dec 2022 CBT

Cabot's (CBT) Earnings and Sales Surpass Estimates in Q4

Cabot's (CBT) results were aided by higher margins and stronger volumes in the fiscal fourth quarter.

02:27 07 Dec 2022 CBT

Cabot Corporation (CBT) Q4 2022 Earnings Call Transcript

Cabot Corporation (NYSE:CBT ) Q4 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Steve Delahunt - Vice President of Investor Relations & Treasurer Sean Keohane - President & Chief Executive Officer Erica McLaughlin - Senior Vice President & Chief Financial Officer Conference Call Participants Anthony Mercandetti - Deutsche Bank James Cannon - UBS Jeff Zekauskas - JPMorgan Laurence Alexander - Jefferies Chris Kapsch - Loop Capital Operator Ladies and gentlemen, thank you for standing by and welcome to Cabot's Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be advised today's conference may be recorded.

05:49 07 Dec 2022 CBT

Cabot Usually Rises On Q4 Earnings - Potential 40% Upside

CBT almost always beats the most optimistic EPS expectations in Q4, leading to a strong earnings trade potential. A discounted cash flow analysis points to a 40% upside in this stock.

09:07 07 Dec 2022 CBT

Cabot Corporation to Announce Fourth Quarter 2022 Operating Results

BOSTON--(BUSINESS WIRE)--Cabot Corporation to Announce Fourth Quarter 2022 Operating Results

08:17 07 Dec 2022 CBT

Cabot's (CBT) Shares Up 17% YTD: What's Driving the Stock?

Cabot (CBT) gains on strong underlying demand across its businesses, its disciplined execution of operations and strategic acquisition.

09:47 07 Dec 2022 CBT

5 Top-Notch Dividend Plays in the Diversified Chemical Industry

Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.

05:30 07 Dec 2022 CBT

Cabot Corporation to Present at the Credit Suisse 35th Annual Specialties & Basics Conference

BOSTON--(BUSINESS WIRE)--Cabot Corporation (NYSE: CBT) announced today that Erica McLaughlin, Senior Vice President and Chief Financial Officer, will present at the Credit Suisse 35th Annual Specialties & Basics Conference in New York on Tuesday, September 13, 2022, at 2:45 p.m. (ET). A live webcast of the presentation, along with the presentation slides and replay will be available on the investor section of Cabot's website http://investor.cabot-corp.com. About Cabot Corporation Cabot Corp

12:48 07 Dec 2022 CBT

Cabot (CBT) Down 1.5% Since Last Earnings Report: Can It Rebound?

Cabot (CBT) reported earnings 30 days ago. What's next for the stock?

11:18 07 Dec 2022 CBT

Cabot (CBT) Recently Broke Out Above the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

09:02 07 Dec 2022 CBT

Cabot (CBT) Up 11% in 3 Months: What's Driving the Stock?

Solid fiscal third quarter results and upbeat outlook have contributed to the run-up in Cabot's (CBT) shares.

CBT Financial details

Company Rating
Strong Buy
Market Cap
4.23B
Income
209M
Revenue
4.32B
Book val./share
15.89
Cash/share
3.65
Dividend
1.48
Dividend %
2.07%
Employees
4.19K
Optionable
No
Shortable
Yes
Earnings
30 Jan 2023
P/E
28.69
Forward P/E
14.15
PEG
-16.63
P/S
0.93
P/B
4.49
P/C
19.66
P/FCF
-36.36
Quick Ratio
0.94
Current Ratio
1.65
Debt / Equity
1.21
LT Debt / Equity
1.21
-
-
EPS (TTM)
3.65
EPS next Y
5.07
EPS next Q
1.02
EPS this Y
-16.04%
EPS next Y
38.88%
EPS next 5Y
38.88%
EPS last 5Y
NAN%
Revenue last 5Y
5.91%
Revenue Q/Q
-3.22%
EPS Q/Q
-2.35%
-
-
-
-
SMA20
1.39%
SMA50
8.96%
SMA100
12.31%
Inst Own
93.46%
Inst Trans
-0.73%
ROA
6%
ROE
24%
ROC
0.16%
Gross Margin
20%
Oper. Margin
9%
Profit Margin
5%
Payout
40%
Shs Outstand
56.33M
Shs Float
55.61M
-
-
-
-
Target Price
-
52W Range
51.09-78.62
52W High
-8.01%
52W Low
+40.69%
RSI
50
Rel Volume
0.42
Avg Volume
358.59K
Volume
149.86K
Perf Week
-1.59%
Perf Month
-0.36%
Perf Quarter
16.65%
Perf Half Y
-8.05%
-
-
-
-
Beta
1.39173
-
-
Volatility
1.3%, 1.96%
Prev Close
0.43%
Price
71.75
Change
-1.97%

CBT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-09-30

Metric History 2018-09-302019-09-302020-09-302021-09-30 2022-09-30
Revenue per share
53.7158.4646.2960.176.48
Net income per share
-1.872.75-4.214.413.7
Operating cash flow per share
4.946.366.684.531.77
Free cash flow per share
1.142.443.131.09-1.96
Cash per share
2.92.962.672.963.65
Book value per share
19.1217.4812.2416.6915.89
Tangible book value per share
18.0216.6110.2214.9812.5
Share holders equity per share
19.1217.4812.2416.6915.89
Interest debt per share
17.5119.6720.6822.8326.53
Market cap
2.99B2.61B2.15B3.03B4.11B
Enterprise value
3.82B3.5B3.11B4.1B5.35B
P/E ratio
-26.4616.61-9.0212.1119.68
Price to sales ratio
0.920.780.820.890.95
POCF ratio
10.037.185.6911.7841.13
PFCF ratio
43.3318.7612.1348.81-37.05
P/B Ratio
2.592.613.113.24.58
PTB ratio
2.592.613.113.24.58
EV to sales
1.181.051.191.21.24
Enterprise value over EBITDA
13.498.0718.977.0510.43
EV to operating cash flow
12.819.658.2515.9753.5
EV to free cash flow
55.3325.217.5766.2-48.19
Earnings yield
-0.040.06-0.110.080.05
Free cash flow yield
0.020.050.080.02-0.03
Debt to equity
0.621.031.580.851.21
Debt to assets
0.610.620.710.670.75
Net debt to EBITDA
2.932.065.881.852.41
Current ratio
1.462.021.851.241.65
Interest coverage
2.895.190.49.276.95
Income quality
-2.642.31-1.581.030.48
Dividend Yield
0.030.030.040.030.01
Payout ratio
-0.710.51-0.340.320.11
Sales general and administrative to revenue
0.090.090.1100
Research and developement to revenue
0.020.020.020.020
Intangibles to total assets
0.060.060.090.070.05
Capex to operating cash flow
-0.77-0.62-0.53-0.76-2.11
Capex to revenue
-0.07-0.07-0.08-0.06-0.05
Capex to depreciation
-1.54-1.51-1.27-1.22-1.45
Stock based compensation to revenue
00000.01
Graham number
28.3832.8934.0740.6936.37
ROIC
0.070.130.010.210.16
Return on tangible assets
-0.040.06-0.090.080.06
Graham Net
-17.51-18.75-23.43-22.97-25.88
Working capital
434M611M449M278M715M
Tangible asset value
1.09B948M577M850M706M
Net current asset value
-579M-660M-989M-791M-807M
Invested capital
0.871.071.611.321.61
Average receivables
641M587.5M531.5M645M740.5M
Average payables
463M435M398M480M0
Average inventory
517M494.5M441M523M593.5M
Days sales outstanding
71.7257.9758.3769.0670.62
Days payables outstanding
66.1553.6854.5667.130
Days of inventory on hand
75.7964.1461.9873.1470.54
Receivables turnover
5.096.36.255.295.17
Payables turnover
5.526.86.695.440
Inventory turnover
4.825.695.894.995.17
ROE
-0.10.16-0.340.260.23
Capex per share
-3.79-3.92-3.54-3.44-3.73

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q4

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
15.9417.1119.2920.4119.68
Net income per share
0.51-1.571.891.721.66
Operating cash flow per share
1.76-0.870.180.61.86
Free cash flow per share
0.35-1.4-0.55-0.280.27
Cash per share
2.963.163.83.693.65
Book value per share
16.6914.0316.2215.915.89
Tangible book value per share
14.9813.0415.1114.9212.5
Share holders equity per share
16.6914.0316.2215.915.89
Interest debt per share
22.1823.4223.8225.3125.86
Market cap
2.84B3.18B3.87B3.59B3.61B
Enterprise value
3.92B4.31B4.99B4.79B4.85B
P/E ratio
24.51-8.939.059.269.6
Price to sales ratio
3.153.283.553.133.25
POCF ratio
28.43-64.89387.2105.6334.38
PFCF ratio
142.16-40.25-124.9-224.46240.65
P/B Ratio
344.224.014.02
PTB ratio
344.224.014.02
EV to sales
4.344.464.574.174.36
Enterprise value over EBITDA
34.4-86.2826.2824.3327.54
EV to operating cash flow
39.21-88.04499.4140.9846.16
EV to free cash flow
196.06-54.61-161.1-299.59323.12
Earnings yield
0.01-0.030.030.030.03
Free cash flow yield
0.01-0.02-0.0100
Debt to equity
0.850.90.771.231.21
Debt to assets
0.670.710.70.710.75
Net debt to EBITDA
9.46-22.685.916.17.03
Current ratio
1.241.211.261.71.65
Interest coverage
6.17-6.9214.6411.27.94
Income quality
3.450.550.090.351.12
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.69-0.240.20.220.44
Sales general and administrative to revenue
00000
Research and developement to revenue
0.020.010.010.010
Intangibles to total assets
0.070.060.060.060.05
Capex to operating cash flow
-0.80.61-4.1-1.47-0.86
Capex to revenue
-0.09-0.03-0.04-0.04-0.08
Capex to depreciation
-1.86-0.77-1.14-1.39-2.57
Stock based compensation to revenue
0000.010.01
Graham number
13.8622.2926.2724.8224.39
ROIC
0.03-0.040.080.070.06
Return on tangible assets
0.01-0.030.030.030.03
Graham Net
-22.97-25.1-23.56-23.59-25.88
Working capital
278M282M371M771M715M
Tangible asset value
850M738M855M840M706M
Net current asset value
-791M-758M-680M-654M-807M
Invested capital
1.321.651.461.581.61
Average receivables
760.5M768M833.5M876M856M
Average payables
609M679M737.5M738M0
Average inventory
593.5M605M648.5M664M664M
Days sales outstanding
64.2161.3665.1968.6267.66
Days payables outstanding
59.572.4777.1372.670
Days of inventory on hand
64.8363.8266.2465.3867
Receivables turnover
1.41.471.381.311.33
Payables turnover
1.511.241.171.240
Inventory turnover
1.391.411.361.381.34
ROE
0.03-0.110.120.110.1
Capex per share
-1.41-0.53-0.72-0.89-1.59

CBT Frequently Asked Questions

What is Cabot Corporation stock symbol ?

Cabot Corporation is a US stock , located in Boston of Massachusetts and trading under the symbol CBT

What is Cabot Corporation stock quote today ?

Cabot Corporation stock price is $71.75 today.

Is Cabot Corporation stock public?

Yes, Cabot Corporation is a publicly traded company.

Something similar

Top Correlated Stocks
Similar Market Cap